Page 21 - YOROZU America Corp.

Complex large claims management and
stop-loss

Actionable cost-containment opportunities

SPECIALTY ORGAN AND
PHARMACY TISSUE IMPLANTS

Clinical strategies:

Diagnosis conirmation

Treatment alternatives
ACTIONABLE Provider optimization
OPPORTUNITIES HIGH RISK
DEFINED ONCOLOGY Pricing negotiation PREGNANCY AND
Predetermined set of medical Treatment protocol
diagnostic categories where NEONATAL
known impact can be made Rx cost containment

Claim audit and re-pricing

Plan design recommendations
Site of care review

ESRD/DIALYSIS HEMOPHILIA

Yorozu America Corp. — Lockton Employee Beneits Practice overview 21 Lockton Companies